Monopar Therapeutics Inc. ( MNPR) - Stock Earnings
MNPR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
MNPR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.2 million USD | — USD |
| 2026Q1 | -3.9 million USD | — USD |
| 2026Q2 | -5.3 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MNPR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.4 million USD | — USD |
| 2024 | -15.6 million USD | — USD |
| 2025 | -13.7 million USD | — USD |
| 2026 Est. | — | — |
MNPR
Price: $69.27
52 week price:
Earnings Per Share: -2.26 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123422
Market Capitalization: 522.3 million